Novel Mitotic Checkpoint Gene
Since abnormal chfr is found only in cancer cells, it may be a target for development of new therapeutic agents or for gene therapy. Additionally, detection of chfr mutations may be useful for identifying cancers that are sensitive to certain chemotherapeutic agents, such as taxol.
U.S. Patent No. 7,176,293.
This technology is available for licensing on a nonexclusive basis.